SEC
EVH icon

Seven Eight Capital’s Evolent Health EVH Stock Holding History

Seven Eight Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,121
Closed -$710K – 205
2024
Q3 		$710K Buy
25,121
+3,356
+15% +$86.5K 0.06% 485
2024
Q2 		$416K Buy
+21,765
New +$556K 0.04% 553
2020
Q4 		– Sell
-16,475
Closed -$204K – 474
2020
Q3 		$204K Buy
+16,475
New +$194K 0.04% 519
2019
Q2 		– Sell
-68,400
Closed -$860K – 629
2019
Q1 		$860K Buy
68,400
+54,407
+389% +$861K 0.05% 377
2018
Q4 		$279K Buy
+13,993
New +$324K 0.02% 482
2017
Q4 		– Sell
-28,781
Closed -$512K – 488
2017
Q3 		$512K Buy
+28,781
New +$593K 0.06% 338

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Seven Eight Capital's EVH Position: Q4 2024 in Review

Seven Eight Capital sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 25,121 shares — an estimated $710K sold.

Seven Eight Capital first reported a position in EVH in Q3 2017 and held it in 6 quarters. The position peaked at $860K in Q1 2019. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Seven Eight Capital reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 25,121 Evolent Health shares in Q4 2024, an estimated $710K.
  • Seven Eight Capital first reported a position in Evolent Health in Q3 2017 and held it in 6 quarters.
  • Seven Eight Capital's Evolent Health position peaked at $860K in Q1 2019.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.